Thursday, 19 Sep 2019

You are here

Arthur F. Kavanaugh, MD: sessions on JAK inhibitors

Dr. Arthur Kavanaugh, MD, Professor of Medicine at the University of California, San Diego School of Medicine, and Director of the Center for Innovative Therapy in the UCSD Division of Rheumatology, Allergy, and Immunology, highlights what he looks forward to learning more about at ACR.

Add new comment

Want to talk about this video? Comment here to lead the discussion.

Brian Lamoreaux on higher comorbidities...

21 Jun 2019

Dr. Uma Mahadevan: Gastroenterology...

11 Feb 2018

The RheumNow Week in Review – 9...

09 Sep 2016

Dr. Jonathan Kay - Biosimilars at EULAR

11 Jul 2016

QD6 - RA and Thrombocytopenia

10 Jan 2019

Dr. Dafna Gladman: Evolving concepts in...

02 Mar 2016

RWCS 2017: Adherence to Therapies: What...

21 Feb 2017

Dr. Arthur Kavanaugh: Safety and...

07 Nov 2017

Dr. Janet Pope: Therapy Effect on...

08 Nov 2017

RheumNow Week in Review – Four Fingers...

12 Oct 2018

Drs. Arthur Kavanaugh, Doug White and...

30 Oct 2018

RheumNow Week in Review – 15 July 2016

15 Jul 2016